Exchange: NASDAQ·Updated 05:51 PM EDT

About

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
17

Frequently Asked Questions

What is Market Cap of SeaStar Medical Holding Corp?
What is the 52-week high for SeaStar Medical Holding Corp?
What is the 52-week low for SeaStar Medical Holding Corp?
What is SeaStar Medical Holding Corp stock price today?
What was SeaStar Medical Holding Corp stock price yesterday?
What is the PE ratio of SeaStar Medical Holding Corp?
What is the Price-to-Book ratio of SeaStar Medical Holding Corp?
What is the 50-day moving average of SeaStar Medical Holding Corp?
How many employees does SeaStar Medical Holding Corp have?

Advertisement|Remove ads.